financetom
Business
financetom
/
Business
/
How Warren Buffett Decides When To Sell a Stock: 'If the Competitive Advantage Disappears...We Sell'
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
How Warren Buffett Decides When To Sell a Stock: 'If the Competitive Advantage Disappears...We Sell'
Dec 29, 2024 12:19 PM

Warren Buffett, renowned for his “buy-and-hold” investment philosophy, rarely sells stocks, making his decision to divest significant stakes a noteworthy event.

Known as the “Sage of Omaha,” Buffett prefers to hold positions indefinitely, only selling when he believes a company's competitive advantage has eroded.

His approach to investing is built on patience and confidence in a business's long-term fundamentals.

"We're more reluctant to sell them than most people," Buffett explained during Berkshire Hathaway's 2009 annual meeting.

"If we made the right decision going in, we like to ride that a very long time, and we've owned some stocks for decades. But if the competitive advantage disappears, if we really lose faith in the management, if we were wrong in the original analysis — and that happens — we sell," Buffett added.

Also Read: Warren Buffett's Timeless Advice For Investing $10,000: ‘If You're Gonna Do Dumb Things Because Your Your Stock Goes Down, You Shouldn’t Own A Stock At All’

Buffett's strategy was evident in his historic investment in newspapers during the 1970s. Back then, he viewed publications like the Omaha World-Herald and Buffalo News as indomitable franchises.

However, the industry faced severe challenges in the early 2000s, as digital platforms eroded advertising revenues. Recognizing these structural changes, Buffett eventually sold his portfolio of around 30 newspapers in early 2020, signaling his belief that their competitive edge had vanished.

This rare shift in Buffett's portfolio management reflects his disciplined approach to identifying and responding to fundamental changes in industries.

His actions underscore the importance of evaluating long-term competitive advantages, even for businesses previously considered untouchable.

Read Next

Warren Buffett’s Stock Market Advice: Ignore Neighbor’s Whispers On Stock Tips, Focus On Long-Term Value

This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
HighPeak Energy Plans $725 Million Senior Notes Offering
HighPeak Energy Plans $725 Million Senior Notes Offering
Jun 30, 2025
08:42 AM EDT, 06/30/2025 (MT Newswires) -- HighPeak Energy ( HPK ) said Monday it plans to offer $725 million of senior notes due 2030 in a private placement. Net proceeds from this new debt issuance, along with borrowings from a new revolving credit facility it expects to enter related to the offering, would be used to fully repay its...
AbbVie to buy Capstan Therapeutics for up to $2.1 billion
AbbVie to buy Capstan Therapeutics for up to $2.1 billion
Jun 30, 2025
(Reuters) -U.S. drugmaker AbbVie said on Monday it will acquire cell therapy developer Capstan Therapeutics in a cash deal worth up to $2.1 billion. Capstan develops CAR-T therapies, a type of treatment that uses a patient's own immune cells, specifically T cells, to fight diseases. Its main drug, CPTX2309, is currently in development for the treatment of autoimmune diseases. AbbVie...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
AbbVie to buy Capstan Therapeutics for up to $2.1 billion
AbbVie to buy Capstan Therapeutics for up to $2.1 billion
Jun 30, 2025
June 30 (Reuters) - AbbVie ( ABBV ) said on Monday it will acquire Capstan Therapeutics in a deal worth up to $2.1 billion, adding experimental treatments for autoimmune diseases to its portfolio. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved